Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SENTINEXT THERAPEUTICS ApS
APS
In liquidation
CVR 32473016
Frederiksborggade 15, 1360
København K
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2009 · 16 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
SENTINEXT THERAPEUTICS ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
1M
2012
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2012
Income statement
DKK thousands
Item
2012
Gross profit
1.405
Staff expenses
-0
EBITDA
101
Depreciation & amort.
-0
EBIT
101
Net financials
-62
Profit before tax
39
Tax
19
Net profit
20
Balance sheet
DKK thousands
Item
2012
Total assets
685
Equity
86
Long-term debt
0
Short-term debt
599
Total debt
599
Financial ratios
5-year trend
EBITDA margin (of gross profit)
7.2%
This company
2012
2012
Equity ratio
12.5%
This company
38.2%
Market median
-67% vs market
2012
2012
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
2012
2012
Net profit margin (of gross profit)
1.4%
This company
2012
2012
Asset turnover (of gross profit)
2.05×
This company
2012
2012
Debt / equity
6.98×
This company
0.62×
Market median
-1026% vs market
2012
2012
Annual reports & filings
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
More on SENTINEXT THERAPEUTICS ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
